Fibromyalgia Treatment Highmark Now Covers FDA-Cleared Fibromyalgia Treatment by Swing Therapeutics
Swing Therapeutics’ Stanza Receives Positive Coverage Decision from Highmark Health for Fibromyalgia Treatment In a major breakthrough for the treatment of fibromyalgia, Swing Therapeutics has announced that Stanza, its innovative…
OA Pain Zoetis Updates U.S. Label for Librela® to Treat Canine Osteoarthritis
OA Pain Zoetis Updates U.S. Label for Librela® to Enhance Support for Veterinarians and Pet Owners OA Pain Zoetis a global leader in animal health, has announced a key update…
Survey 88% of Western Europeans Seek Better Breast Cancer Info
Bridging the Breast Cancer Awareness Gap: Insights from a Pan-European Survey A newly released survey, sponsored by Daiichi Sankyo and AstraZeneca, underscores the urgent need for more accessible and accurate…
Pepto-Bismol Beyond Pink – 5 Symptom Relief You Can Trust
Pepto-Bismol The Ultimate Solution for Five Common Digestive Issues Did you know that gastrointestinal (GI) issues affect a significant portion of the UK population each year? Research indicates that approximately…
Tonix Pharmaceuticals Appoints Siobhan Fogarty as Chief Technical Officer
Tonix Pharmaceuticals Appoints Siobhan Fogarty as Chief Technical Officer Tonix Pharmaceuticals Holding a fully integrated biopharmaceutical company specializing in the development and commercialization of innovative therapies for pain management and…
Disease Control Pioneer Dr. Daniel L. Shungu Recognized by Marquis Who’s Who for Leadership
Marquis Who’s Who Recognizes Dr. Daniel L. Shungu for Leadership in Disease Control Daniel L. Shungu, PhD, has been honored with inclusion in Marquis Who’s Who, a prestigious recognition awarded…
Cagent Vascular Unveils New Serranator SL-PRO Product for CLTI and Pedal Disease
Cagent Vascular Announces the Launch of Serranator SL-PRO™ for Pedal and Tibial Disease Treatment Cagent Vascular a leader in the development of cutting-edge serration technology for vessel dilation in endovascular…
Enveric Biosciences Completes $5 Million Public Offering
Enveric Biosciences Completes $5 Million Public Offering Enveric Biosciences a leading biotechnology company focused on the development of groundbreaking neuroplastogenic small-molecule therapeutics, has made a significant advancement in its efforts…
Patient-Centric Medidata Pioneers AI-Driven Innovations
Patient-Centric Medidata Leading the Future of Life Sciences with AI-Powered Innovations and Patient-Centric Experiences Patient-Centric Medidata, a Dassault Systèmes brand, continues to solidify its role as a pioneering force in…
Algiax Reports Positive Phase 2a Results for AP-325 in Neuropathic Pain
Reports Algiax Pharmaceuticals Announces Positive Phase 2a Results for AP-325 in Neuropathic Pain Reports Algiax Pharmaceuticals, a clinical-stage biotechnology company dedicated to developing innovative therapies for chronic neuropathic pain, has…
NSCLC Patients Nuvation Bio Launches U.S. Expanded Access Program for Taletrectinib in ROS1
Nuvation Bio Expands Access to Taletrectinib for Advanced ROS1-Positive NSCLC Patients in the U.S. Nuvation Bio a leading global biopharmaceutical company focused on developing innovative therapies for some of the…
DNAnexus Strengthens Veeva Partnership for Global Regulatory Collaboration
DNAnexus Expands Relationship with Veeva to Advance Global Regulatory Collaboration DNAnexus, a global leader in regulatory cloud services, has announced the expansion of its collaboration with Veeva Systems, a prominent…